[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
…, MG Patel, BR Saville, J Marion, E Ogburn… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …
…, BR Saville, O Gbinigie, O Van Hecke, E Ogburn… - The Lancet, 2021 - thelancet.com
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
[HTML][HTML] Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised …
Background Studies evaluating titration of antihypertensive medication using self-monitoring
give contradictory findings and the precise place of telemonitoring over self-monitoring …
give contradictory findings and the precise place of telemonitoring over self-monitoring …
[HTML][HTML] Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised …
Background Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties,
has been used to treat COVID-19, but evidence from community randomised trials is …
has been used to treat COVID-19, but evidence from community randomised trials is …
Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial
Objective The HOME BP (Home and Online Management and Evaluation of Blood Pressure)
trial aimed to test a digital intervention for hypertension management in primary care by …
trial aimed to test a digital intervention for hypertension management in primary care by …
[HTML][HTML] Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled …
…, J Kirkpatrick, S de Lusignan, E Ogburn… - The Lancet …, 2021 - thelancet.com
Background Doxycycline is often used for treating COVID-19 respiratory symptoms in the
community despite an absence of evidence from clinical trials to support its use. We aimed to …
community despite an absence of evidence from clinical trials to support its use. We aimed to …
[HTML][HTML] Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label …
Background Insomnia is prevalent and distressing but access to the first-line treatment,
cognitive behavioural therapy (CBT), is extremely limited. We aimed to assess the clinical and …
cognitive behavioural therapy (CBT), is extremely limited. We aimed to assess the clinical and …
Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study
…, D Lasserson, RJ McManus, E Ogburn… - British Journal of …, 2020 - bjgp.org
Background Chronic kidney disease (CKD) is a largely asymptomatic condition of diminished
renal function, which may not be detected until advanced stages without screening. Aim To …
renal function, which may not be detected until advanced stages without screening. Aim To …
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
…, BR Saville, O Gbinigie, O Van Hecke, E Ogburn… - British Journal of …, 2022 - bjgp.org
Background Colchicine has been proposed as a COVID-19 treatment. Aim To determine
whether colchicine reduces time to recovery and COVID-19-related admissions to hospital and/…
whether colchicine reduces time to recovery and COVID-19-related admissions to hospital and/…
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
…, BR Saville, O Gbinigie, O Van Hecke, E Ogburn… - Medrxiv, 2021 - medrxiv.org
BACKGROUND Inhaled budesonide has shown efficacy for treating COVID-19 in the
community but has not yet been tested in effectiveness trials. METHODS We performed a …
community but has not yet been tested in effectiveness trials. METHODS We performed a …